** Shares of Archer Materials AXE.AX rise as much as 13.3% to A$0.34, highest level since February 26
** Semiconductor technology company enters partnership with Hylid Diagnostics to develop an at-home testing device for chronic kidney disease as part of its Biochip project
** About 279,150 shares change hands by 0057 GMT, 1.3 times the 30-day average volume of shares
** Stock down 48.3% this year, as of last close
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。